<VariationArchive VariationID="2825275" VariationName="NM_000406.3(GNRHR):c.351_352del (p.Ser118fs)" VariationType="Deletion" Accession="VCV002825275" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2024-02-20" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2986360" VariationID="2825275">
      <GeneList>
        <Gene Symbol="GNRHR" FullName="gonadotropin releasing hormone receptor" GeneID="2798" HGNC_ID="HGNC:4421" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="67737118" stop="67754388" display_start="67737118" display_stop="67754388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="68603092" stop="68621803" display_start="68603092" display_stop="68621803" Strand="-" />
          </Location>
          <OMIM>138850</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000406.3(GNRHR):c.351_352del (p.Ser118fs)</Name>
      <CanonicalSPDI>NC_000004.12:67753983:TG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="67753984" stop="67753985" display_start="67753984" display_stop="67753985" variantLength="2" positionVCF="67753983" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="68619702" stop="68619703" display_start="68619702" display_stop="68619703" variantLength="2" positionVCF="68619701" referenceAlleleVCF="CTG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S118fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.68619702_68619703del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.68619702_68619703del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.67753984_67753985del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.67753984_67753985del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009293.1" sequenceAccession="NG_009293" sequenceVersion="1" change="g.7102_7103del">
            <Expression>NG_009293.1:g.7102_7103del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000406.3" sequenceAccession="NM_000406" sequenceVersion="3" change="c.351_352del" MANESelect="true">
            <Expression>NM_000406.3:c.351_352del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000397.1" sequenceAccession="NP_000397" sequenceVersion="1" change="p.Ser118fs">
            <Expression>NP_000397.1:p.Ser118fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012763.2" sequenceAccession="NM_001012763" sequenceVersion="2" change="c.351_352del">
            <Expression>NM_001012763.2:c.351_352del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012781.1" sequenceAccession="NP_001012781" sequenceVersion="1" change="p.Ser118fs">
            <Expression>NP_001012781.1:p.Ser118fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000406.3(GNRHR):c.351_352del (p.Ser118fs) AND not provided" Accession="RCV003680976" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000406.3(GNRHR):c.351_352del (p.Ser118fs) AND Isolated congenital hypogonadotropic hypogonadism" Accession="RCV004017999" Version="2">
        <ClassifiedConditionList TraitSetID="40989">
          <ClassifiedCondition DB="MedGen" ID="C5679849">Isolated congenital hypogonadotropic hypogonadism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-03-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-20" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12050282</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22745237</ID>
        </Citation>
        <DescriptionHistory Dated="2024-04-20">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="40989" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38778" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="MIM" ID="146110" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Isolated congenital hypogonadotropic hypogonadism</ElementValue>
                <XRef ID="MONDO:0016553" DB="MONDO" />
                <XRef ID="238666" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">IHH</ElementValue>
                <XRef Type="MIM" ID="146110" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20643" />
                <XRef ID="20643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Isolated gonadotropin-releasing hormone (GnRH) deficiency (IGD) is characterized by inappropriately low serum concentrations of the gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone) in the presence of low circulating concentrations of sex steroids. IGD is associated with a normal sense of smell (normosmic IGD) in approximately 40% of affected individuals and an impaired sense of smell (Kallmann syndrome) in approximately 60%. IGD can first become apparent in infancy, adolescence, or adulthood. Infant boys with congenital IGD often have micropenis and cryptorchidism. Adolescents and adults with IGD have clinical evidence of hypogonadism and incomplete sexual maturation on physical examination. Adult males with IGD tend to have prepubertal testicular volume (i.e., &lt;4 mL), absence of secondary sexual features (e.g., facial and axillary hair growth, deepening of the voice), decreased muscle mass, diminished libido, erectile dysfunction, and infertility. Adult females have little or no breast development and primary amenorrhea. Although skeletal maturation is delayed, the rate of linear growth is usually normal except for the absence of a distinct pubertal growth spurt.</Attribute>
                <XRef ID="NBK1334" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <XRef ID="238666" DB="Orphanet" />
              <XRef ID="C5679849" DB="MedGen" />
              <XRef ID="MONDO:0016553" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8213932" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="18142639|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004422198" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12050282</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22745237</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser118Leufs*50) in the GNRHR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GNRHR are known to be pathogenic (PMID: 12050282, 22745237). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GNRHR-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNRHR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.68619702_68619703del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056839" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="111939417|Orphanet:ORPHA238666" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004847481" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Comment>The p.Ser118LeufsX50 variant in GNRHR has not been previously reported in individuals with hypogonadotropic hypogonadism nor in large population studies (gnomAD, v4.0.0). This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 118 and leads to a premature termination codon 50 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of function of the GNRHR gene is an established disease mechanism in autosomal recessive hypogonadotropic hypogonadism. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive hypogonadotropic hypogonadism. ACMG/AMP Criteria applied: PVS1, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNRHR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000406.3:exon 1</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.12:g.67753984_67753985delTG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA238666" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9056839" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA238666" MappingRef="Orphanet">
        <MedGen CUI="C5679849" Name="Isolated congenital hypogonadotropic hypogonadism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8213932" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

